Ongoing

CRC Projects Round 17 - Novel precision medicine for FacioScapuloHumoral Muscular Dystrophy (FSHD)

Funding

$850,000

Region

Australia

View Official Page

Overview

This project aims to apply advances in RNA and peptide chemistry to develop a new generation of precision medicines with potential to modify disease in FacioScapuloHumoral Dystrophy (FSHD). The innovation addresses barriers to systemic delivery, muscle and cell uptake, stability and safety. The project will generate proof of concept for muscle targeting of precision therapeutics in relevant models of FSHD.

Eligibility Requirements

Project involves collaborative partnerships between industry, research organizations, and universities. Participants must be part of an approved CRC Projects consortium.

Who Can Apply

Nonprofit

Relevant Industries

HealthBiotechnology

How to Apply

Applications are submitted through the official government portal. Review the eligibility criteria carefully before applying, and ensure all supporting documents are prepared.

Visit the official application page

Disclaimer: Grant information is sourced from official government websites and updated regularly. Always verify current eligibility and deadlines on the official program page before applying.

Related Grants

Ongoing·Commonwealth

Cooperative Research Centres (CRC) Grants - Cell Therapy Manufacturing

The Cell Therapy Manufacturing Cooperative Research Centre (CTM CRC) is funded by the Australian Government to develop innovative cell therapy manufacturing technologies. The CRC focuses on creating stem cell delivery systems for chronic wound treatment and developing scalable production methods for immune cell therapies used in cancer and other medical conditions.

Ongoing·Commonwealth

Research and Development Tax Incentive (RDTI)

A tax incentive program that supports companies conducting research and development activities in Australia. The RDTI enables companies to take risks and perform experiments where outcomes are uncertain, helping to build research infrastructure and attract investment in sectors like biotechnology.

Ongoing·Commonwealth·$800,000 - $19,200,000

Blood Borne Viruses (BBV) and Sexually Transmissible Infections (STI) Research Program

This grant program is delivered, in part, through the collection of data, ongoing surveillance, and pertinent research and evaluation activities related to the BBV and STI outlined in the National BBV and STI Strategies, namely: National Hepatitis B Strategy National Hepatitis C Strategy National STI Strategy National Aboriginal and Torres Strait Islander BBV and STI Strategy National HIV Strategy. The Department’s First National BBV and STI Research Strategy 2021-2025 and its future iterations (the National BBV and STI Research Strategy), sets out the aims and objectives for the multi-disciplinary research activities undertaken within Australia and supports the implementation of the related National BBV and STI Strategies. By enabling and focussing on the conduct of BBV and STI research, the Research Strategy aims to identify challenges, barriers and opportunities to achieve the agreed national goals and targets of the National BBV and STI Strategies. The Research Strategy also contai